A manufacturer markets a new OTC analgesic in sustained rele…
A manufacturer markets a new OTC analgesic in sustained release tablet form. The product uses a foil seal over the bottle opening and a band around the bottle cap as tamper-evident features. The labeling includes a statement about these features, which is printed on the foil seal itself. Which of the following best describes the regulatory concern with this labeling practice?